N Higuchi, M Kato, Y Shundo, H Tajiri, M … - Hepatol Res, 2008 - interscience.wiley.com Aim: Nonalcoholic fatty liver disease (NAFLD) is one of the most frequent causes
of liver dysfunction and its incidence has increased markedly. However, the
mechanisms involved in the pathogenesis of NAFLD in humans have not been ... Cited by 14 - Related articles - All 3 versions
- ►nursing2008.com K Cusi - Current Opinion in Endocrinology, Diabetes and …, 2009 - journals.lww.com Recent findings: The perception of nonalcoholic fatty liver disease as an
uncommon and benign condition is rapidly changing. Approximately 70% of persons
with type 2 diabetes mellitus have a fatty liver and the disease follows a ... Cited by 8 - Related articles - All 6 versions
- ►nursing2008.com KA Le, M Bortolotti - Current Opinion in Clinical Nutrition & Metabolic Care, 2008 - journals.lww.com Introduction Nonalcoholic fatty liver disease (NAFLD) belongs to the broad
family of obesity-related disorders. It is defined as the accumulation of lipid
droplets within hepatocytes, so-called hepatic steatosis, in individuals ... Cited by 6 - Related articles - All 5 versions
R Ali, K Cusi - Annals of Medicine, 2009 - informahealthcare.com Non-alcoholic fatty liver disease or NAFLD is a chronic liver condition
characterized by hepatic steatosis and associated with insulin resistance and
type 2 diabetes mellitus (T2DM). In many patients fat accumulation leads to ... Cited by 5 - Related articles - All 6 versions
MH Ahmed, CD Byrne - Diabetes, Obesity & Metabolism, 2009 - nursing2008.com Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver
disease in Western World and frequently associated with insulin resistance and
overweight and occurs often with type 2 diabetes. Interestingly, NAFLD is ... Cited by 4 - Related articles - Cached - All 7 versions
A Fraser, R Abel, DA Lawlor, D Fraser, A … - Diabetologia, 2008 - Springer Abstract Aim The aim of the study was to compare the effect of different dietary
interventions on alanine aminotransferase (ALT) in obese patients with diabetes.
Methods A post hoc analysis of an open label, parallel design, ... Cited by 4 - Related articles - All 3 versions
L Moller, H Stodkilde-Jorgensen, F Jensen, J … - Clinical Science, 2008 - submit.clinsci.org The impact of fasting on IHL (intrahepatic lipid) content in human subjects has
not been investigated previously, but results indicate that it may change
rapidly in response to metabolic cues. The aim of the present study was to ... Cited by 3 - Related articles - Cached - BL Direct - All 7 versions
GF Watts, SK Gan - Current Opinion in Lipidology, 2008 - journals.lww.com Nonalcoholic fatty liver disease (NAFLD) is increasingly afflicting a large
sector of our community and, beyond its transformation into cirrhosis and
end-stage liver disease [1] , is now recognized as a barometer of ... Cited by 3 - Related articles - BL Direct - All 4 versions
K Cusi - Springer The epidemic of type 2 diabetes (T2DM) is a public health problem that threatens
to spiral out of control in the twenty-first century. Early intervention can
greatly mitigate the serious socioeconomic impact of the disease, driven ... Cited by 2 - Related articles - All 2 versions
- ►ajcn.org C Gasteyger, TM Larsen, F Vercruysse, A … - American Journal of Clinical Nutrition, 2008 - Am Soc Nutrition Background:Weight loss was shown to be associated with improvements in liver
enzymes and improvements of nonalcoholic fatty liver disease. However, some
evidence also shows that liver enzymes may transiently increase immediately ... Cited by 2 - Related articles - BL Direct - All 6 versions
